Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
15,281,921
-
Shares change
-
-380,377
-
Total reported value, excl. options
-
$1,156,290,505
-
Value change
-
-$22,925,000
-
Put/Call ratio
-
123%
-
Number of buys
-
85
-
Number of sells
-
78
-
Price
-
$75.66
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q2 2018
As of 30 Jun 2018 EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) had 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,281,921 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, BlackRock Inc., Park West Asset Management LLC, Hudson Executive Capital LP, IRIDIAN ASSET MANAGEMENT LLC/CT, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, LSV ASSET MANAGEMENT, and JW Asset Management, LLC.
This table shows 211 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.